Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
High quality Bioluminescence and X-Ray analysis in lung squamous cell carcinoma
Jul 21, 2021
Spectral Instruments Imaging provides unrivaled sensitivity for bioluminescence, fluorescence and X-Ray for in vivo...
Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry
Jul 15, 2021
One of the key advantages of spectral flow cytometry is its ability to extract sample autofluorescence, making it much...
Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility
Jul 13, 2021
6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full spectrum flow cytometer for their...
ACCELA webinar recording : IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jul 13, 2021
Intravital microscopy can visualize...
Introducing IZON Exoid: accurate analysis of nanoparticles from 1 to 1000 nm
Jul 7, 2021
The IZON Exoid is the only standardisable method of measuring the entire nano range (1–1000 nm).
Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease
Jul 6, 2021
Understanding how cells organize the array of components within their membranous confines can not only provide insight...
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles
Jun 23, 2021
Overactivation of the PI3K/mTOR signaling has been identified in non-Hodgkin’s lymphoma. BEZ235 is an effective dual...
Microvascular injury in mild traumatic brain injury accelerates alzheimer-like pathogenesis in mice
Jun 22, 2021
Traumatic brain injury (TBI) is considered as the most robust environmental risk factor for Alzheimer’s disease....
Differentation displacement in acute myeloid leukemia through enhancer activation
Aug 7, 2018
LSD1 is a flavin adenine dinucleotide (FAD)-dependent homolog of the amine oxidase family and there was recently brought attention to it as a potential therapeutic target. The interest came from an observation of unusually high expression of LSD1 in certain types of poor-prognosis cancers. It was previously thought that LSD1 removes monomethyl and dymethyl histone marks. However, recently it was showed that it interacts with multiple transcripton factor. This raised a possibility of other drugs being used.
New inhibitor ORY-1001 was succesfully tested on LSD1 and blast cell differentioation was observed. The flow cytometric testing on this experiment was done with Novocyte. ORY-1001 disrupts the protein interaction between LSD1 and GFI1.
Related technologies: Conventional flow cytometry
Get more info
Brand profile
